...
首页> 外文期刊>Haematologica >Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas | Haematologica
【24h】

Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas | Haematologica

机译:原发性纵隔B细胞淋巴瘤:BCL6基因的超突变靶向的基序与弥漫性大B细胞和滤泡性淋巴瘤不同血液学

获取原文

摘要

BACKGROUND AND OBJECTIVES: Somatic hypermutation of the BCL6 gene and its expression in lymphoma represent specific markers for B-cell transit through the germinal center. Thus, analysis of BCL6 may aid in clarifying the relationship between primary mediastinal B-cell lymphoma (PMBL) and other non-thymic diffuse large cell lymphomas (DLCL). DESIGN AND METHODS: Twenty-four PMBL were analyzed for BCL6 status, including first intron mutations, by quantitative reverse transcription polymerase chain reaction (RT-PCR), and immunohistochemistry. We also performed a meta-analysis of reported BCL6 mutations in PMBL (n=141), DLCL (n=233), and follicular lymphoma (n=120). RESULTS: Thirteen PMBL (54%) showed hypermutation of BCL6. All cases showed bcl6 mRNA and immunohistochemical expression. Meta-analysis demonstrated that the preferentially altered sequence motifs of BCL6 in PMBL were TA (p=0.002) and AT (p=0.0008) dinucleotides and TAT trinucleotides (p=0.001). GC and RGYW/WRCY motifs were a target in DLCL and FL but not in PMBL. Moreover, the DNA stretch spanning nucleotides 150-270 was highly targeted only in PMBL. INTERPRETATION AND CONCLUSIONS: The consistent expression of bcl6 protein and occurrence of hypermutation indicate that PMBL should be considered of germinal center origin. The fact that the hypermutation sites and mutational spectrum of BCL6 in PMBL differ from those found in FL and DLCL might suggest that the maturation block of the transforming cells differs among these tumor types, and that the characteristic mutational pattern is present before neoplastic transformation. Thus, our findings strengthen the hypothesis that PMBL originate from an already defined sub-population of B-cells, which are different from those leading to either DLCL or FL.
机译:背景和目的:BCL6基因的体细胞超突变及其在淋巴瘤中的表达代表B细胞通过生发中心转运的特定标记。因此,对BCL6的分析可能有助于阐明原发性纵隔B细胞淋巴瘤(PMBL)与其他非胸腺弥漫性大细胞淋巴瘤(DLCL)之间的关系。设计与方法:通过定量逆转录聚合酶链反应(RT-PCR)和免疫组织化学分析了24个PMBL的BCL6状态,包括第一个内含子突变。我们还对报道的PMBL(n = 141),DLCL(n = 233)和滤泡性淋巴瘤(n = 120)中BCL6突变进行了荟萃分析。结果:13例PMBL(54%)显示BCL6超突变。所有病例均显示bcl6 mRNA和免疫组化表达。荟萃分析表明,PMBL中BCL6优先改变的序列基序为TA(p = 0.002)和AT(p = 0.0008)二核苷酸和TAT三核苷酸(p = 0.001)。 GC和RGYW / WRCY基序是DLCL和FL中的目标,但不是PMBL中的目标。而且,跨越核苷酸150-270的DNA延伸仅在PMBL中高度靶向。结论和结论:bcl6蛋白的一致表达和超突变的发生表明PMBL应考虑为生发中心起源。 PMBL中BCL6的超突变位点和突变谱与FL和DLCL中发现的突变位点和突变谱不同可能表明,转化细胞的成熟块在这些肿瘤类型之间有所不同,并且特征性突变模式在肿瘤转化之前就已经存在。因此,我们的发现加强了这样的假设:PMBL源自已经定义的B细胞亚群,与导致DLCL或FL的亚群不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号